Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
337.97
-2.84 (-0.83%)
At close: Nov 13, 2026, 4:00 PM EST
339.00
+1.03 (0.30%)
After-hours: Nov 13, 2026, 7:42 PM EST
CRL Market Cap
CRL has a market cap or net worth of $16.19 billion as of November 13, 2026. It is the 1,425th most valuable company in the world and the 552nd biggest in the United States. Its market cap has increased by 91.87% in one year.
Market Cap
16.19B
Enterprise Value
18.85B
1-Year Change
91.87%
Global Rank
Country Rank
#552 United States
Category
ChartMarket Cap Chart
Since June 23, 2000, CRL's market cap has increased from $226.30M to $16.19B, an increase of 7,056.28%. That is a compound annual growth rate of 17.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 16.19B | 64.96% |
| Dec 31, 2025 | 9.82B | 4.00% |
| Dec 31, 2024 | 9.44B | -22.16% |
| Dec 29, 2023 | 12.13B | 9.38% |
| Dec 30, 2022 | 11.09B | -41.69% |
| Dec 31, 2021 | 19.01B | 52.98% |
| Dec 31, 2020 | 12.43B | 66.59% |
| Dec 31, 2019 | 7.46B | 37.05% |
| Dec 31, 2018 | 5.44B | 5.01% |
| Dec 29, 2017 | 5.18B | 43.75% |
| Dec 30, 2016 | 3.61B | -3.79% |
| Dec 31, 2015 | 3.75B | 25.52% |
| Dec 31, 2014 | 2.99B | 17.00% |
| Dec 31, 2013 | 2.55B | 40.28% |
| Dec 31, 2012 | 1.82B | 34.64% |
| Dec 30, 2011 | 1.35B | -34.13% |
| Dec 31, 2010 | 2.05B | -7.60% |
| Dec 31, 2009 | 2.22B | 25.20% |
| Dec 31, 2008 | 1.77B | -60.32% |
| Dec 31, 2007 | 4.47B | 54.46% |
| Dec 29, 2006 | 2.89B | -5.57% |
| Dec 30, 2005 | 3.06B | 2.77% |
| Dec 31, 2004 | 2.98B | 89.75% |
| Dec 31, 2003 | 1.57B | -9.52% |
| Dec 31, 2002 | 1.74B | 17.55% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IQVIA Holdings | 44.68B |
| Mettler-Toledo International | 34.43B |
| Illumina | 31.68B |
| Labcorp Holdings | 30.23B |
| Quest Diagnostics | 28.57B |
| Guardant Health | 20.95B |
| Medpace Holdings | 18.37B |
| Revvity | 17.53B |